HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TriStrata patent infringement suit

This article was originally published in The Rose Sheet

Executive Summary

BeautiControl will license alpha hydroxy acid technology from NeoStrata subsidiary TriStrata under a settlement agreement announced Sept. 28. TriStrata filed a lawsuit in Wilmington, Del. federal court alleging direct-seller infringed firm's AHA patent for the reduction of wrinkles and treatment of signs of aging. Company also has lawsuits pending against Valeant Pharmaceuticals and Mary Kay Cosmetics. TriStrata pursued litigation against a number of companies, including Chanel, Clarins and L'Oréal, beginning in 1996, when it discovered the firms were allegedly using its AHA technology without a licensing agreement...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS012504

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel